secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mirum Pharmaceuticals, Inc. (MIRM)
CIK:        0001759425
Form:       8-K
Filed at:   2023-04-06T23:59:59+00:00
Accession:  0001193125-23-093126
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Mirum appoints Timothy Walbert to Board; Niall O'Donnell to resign at 2023 annual meeting
--------------------------------------------------------------------------------

- Timothy Walbert appointed to Board as Class I director effective April 5, 2023.
- Walbert receives option for 34,000 shares vesting over 3 years and $45,000 annual cash retainer.
- Niall O'Donnell resigns as director and from Nominating and Corporate Governance Committee, effective at 2023 annual meeting, no dispute.
- Walbert will serve until 2023 annual meeting and then be eligible for annual option grant of 17,000 shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1759425/000119312523093126/0001193125-23-093126-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1759425/000119312523093126/d462977d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-093126

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer